Animal bites have always been a common problem to humans. The incidence of resistant organisms is also increasing in the community. Garenoxacin a novel oral des-fluoroquinolone with potent antimicrobial activity against common pathogens causing skin and soft tissue infections, including resistant strains offers the benefit of broad spectrum of coverage including gram positive, gram negative and anaerobic organisms. The result of the case study indicates that garenoxacin is very effective in treating skin and soft tissue infections caused by animal bites.
Select your language of interest to view the total content in your interested language